MicroRNA regulators of vascular pathophysiology in chronic kidney disease

Clin Chim Acta. 2023 Nov 1:551:117610. doi: 10.1016/j.cca.2023.117610. Epub 2023 Oct 18.

Abstract

Coronary artery disease (CAD) is a severe comorbidity in chronic kidney disease (CKD) due to heavy calcification in the medial layer and inflamed plaques. Chronic inflammation, endothelial dysfunction and vascular calcification are major contributors that lead to artherosclerosis in CKD. The lack of specific symptoms and signs of CAD and decreased accuracy of noninvasive diagnostic tools result in delayed diagnosis leading to increased mortality. MicroRNAs (miRNAs) are post-transcriptional regulators present in various biofluids throughout the body. In the circulation, miRNAs have been reported to be encapsulated in extracellular vesicles and serve as stable messengers for crosstalk among cells. miRNAs are involved in pathophysiologic mechanisms including CAD and can potentially be extended from basic research to clinical translational practice.

Keywords: Chronic kidney disease; Coronary artery disease; MicroRNA.

Publication types

  • Review

MeSH terms

  • Coronary Artery Disease* / diagnosis
  • Humans
  • MicroRNAs* / genetics
  • Plaque, Atherosclerotic*
  • Renal Insufficiency, Chronic* / genetics
  • Vascular Calcification* / genetics

Substances

  • MicroRNAs